Company VioQuest Pharmaceuticals, Inc. Other OTC
Equities
VOQP
US9276252023
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Asymmetric Products and Technology
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark D. Dacko
AUD | Comptroller/Controller/Auditor | 72 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 08/02/09 | |
Mark D. Dacko
AUD | Comptroller/Controller/Auditor | 72 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,461,644 | 5,461,644 ( 100.00 %) | 0 | 100.00 % |
Company contact information
VioQuest Pharmaceuticals, Inc.
PO Box 2287
55402, Minneapolis
+
Sector
1st Jan change | Capi. | |
---|---|---|
+5.21% | 111B | |
+11.38% | 105B | |
-11.88% | 22.34B | |
-3.76% | 21.93B | |
-6.13% | 18.59B | |
-36.52% | 18.12B | |
-10.32% | 16.96B | |
+4.09% | 13.7B | |
+38.49% | 12.45B |